億道信息(001314.SZ):億境自定義研發的高性價比輕量級MR產品的銷售推廣正在有序推進中
格隆匯1月5日丨有投資者於投資者互動平台向億道信息(001314.SZ)提問,“請問公司的MR產品是否已經投入市場?具體銷售價格如何?從哪些平台可以購買體驗?”,公司回覆稱,億境自定義研發的高性價比輕量級MR產品的銷售推廣正在有序推進中,在深圳主流覆蓋全球的電子產品市場有展示樣機,歡迎體驗並提供寶貴建議。此款產品具體終端售價及正式購買平台取決於不同銷售渠道的商業規劃。MR處於行業發展早期階段且可能存在較多變數,請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.